Literature DB >> 15473496

Quantitative assessment of changes in patients' constructs of quality of life: an application of multilevel models.

Adam Lowy1, Jürg Bernhard.   

Abstract

It has often been proposed that quality of life (QL) instruments should account for potentially changing conceptualisations of QL as patients adapt to disease (response-shift). Most instruments do not do this, and some that do are relatively complicated and burdensome for patients. The extent to which patients reconceptualise QL is unknown, and it is unclear whether this additional complication is necessary. This paper reviews existing methods for assessing response-shift and introduces an alternative approach using multilevel models. The method is described using data from a cancer clinical trial, and its performance is evaluated in simulations. The models reveal substantial response-shift in these cancer patients. Simulations under the null hypothesis of zero response-shift confirm that the method performs correctly in terms of its risk of type I error, and further simulations illustrate its statistical power to detect pre-defined levels of response-shift. The method is a relatively simple extension of familiar multiple regression models and yields parameters with a simple interpretation, representing the changes in importance of QL domains over time. It can be applied to existing datasets collected with other analysis strategies in mind and may have application in the investigation of response shifts and other manifestations of adaptation.

Entities:  

Mesh:

Year:  2004        PMID: 15473496     DOI: 10.1023/B:QURE.0000037510.17893.d2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  27 in total

1.  The challenge of response shift for quality-of-life-based clinical oncology research.

Authors:  M A Sprangers; C E Schwartz
Journal:  Ann Oncol       Date:  1999-07       Impact factor: 32.976

2.  Why are we weighting? The role of importance ratings in quality of life measurement.

Authors:  T Trauer; A Mackinnon
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

3.  The influence of ill-health experience on the valuation of health.

Authors:  X Badia; M Herdman; P Kind
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

4.  Health related quality of life: a changing construct?

Authors:  Jürg Bernhard; Adam Lowy; Natascha Mathys; Richard Herrmann; Christoph Hürny
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

5.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

6.  Deriving a preference-based single index from the UK SF-36 Health Survey.

Authors:  J Brazier; T Usherwood; R Harper; K Thomas
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

7.  The disability paradox: high quality of life against all odds.

Authors:  G L Albrecht; P J Devlieger
Journal:  Soc Sci Med       Date:  1999-04       Impact factor: 4.634

8.  Factor analysis, causal indicators and quality of life.

Authors:  P M Fayers; D J Hand
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

9.  Explaining quality of life with crisis theory.

Authors:  Mirjam A G Sprangers; Reike Tempelaar; Wim J A van den Heuvel; Hanneke C J M de Haes
Journal:  Psychooncology       Date:  2002 Sep-Oct       Impact factor: 3.894

10.  The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).

Authors:  C Hürny; J Bernhard; M Bacchi; B van Wegberg; M Tomamichel; U Spek; A Coates; M Castiglione; A Goldhirsch; H J Senn
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

View more
  7 in total

1.  Health related quality of life: a changing construct?

Authors:  Jürg Bernhard; Adam Lowy; Natascha Mathys; Richard Herrmann; Christoph Hürny
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

2.  Response shift: a brief overview and proposed research priorities.

Authors:  Ruth Barclay-Goddard; Joshua D Epstein; Nancy E Mayo
Journal:  Qual Life Res       Date:  2009-02-25       Impact factor: 4.147

Review 3.  Scoping review of response shift methods: current reporting practices and recommendations.

Authors:  Tolulope T Sajobi; Ronak Brahmbatt; Lisa M Lix; Bruno D Zumbo; Richard Sawatzky
Journal:  Qual Life Res       Date:  2017-12-05       Impact factor: 4.147

Review 4.  A systematic review of the quality of reporting of simulation studies about methods for the analysis of complex longitudinal patient-reported outcomes data.

Authors:  Aynslie M Hinds; Tolulope T Sajobi; Véronique Sebille; Richard Sawatzky; Lisa M Lix
Journal:  Qual Life Res       Date:  2018-04-20       Impact factor: 4.147

5.  Relative importance measures for reprioritization response shift.

Authors:  Lisa M Lix; Tolulope T Sajobi; Richard Sawatzky; Juxin Liu; Nancy E Mayo; Yuhui Huang; Lesley A Graff; John R Walker; Jason Ediger; Ian Clara; Kathryn Sexton; Rachel Carr; Charles N Bernstein
Journal:  Qual Life Res       Date:  2012-06-15       Impact factor: 4.147

6.  Critical examination of current response shift methods and proposal for advancing new methods.

Authors:  Véronique Sébille; Lisa M Lix; Olawale F Ayilara; Tolulope T Sajobi; A Cecile J W Janssens; Richard Sawatzky; Mirjam A G Sprangers; Mathilde G E Verdam
Journal:  Qual Life Res       Date:  2021-02-17       Impact factor: 4.147

7.  Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer.

Authors:  J Bernhard; D Zahrieh; A S Coates; R D Gelber; M Castiglione-Gertsch; E Murray; J F Forbes; L Perey; J Collins; R Snyder; C-M Rudenstam; D Crivellari; A Veronesi; B Thürlimann; M F Fey; K N Price; A Goldhirsch; C Hürny
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.